Skip to main content
Springer Nature Link
Log in

Clindamycin/Tretinoin

Clindamycin Phosphate/Tretinoin Gel

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Connetics Corporation. Connetics Licenses Velac(R) Gel From Yamanouchi. Media Release: 14 May 2002. Available from URL: http://www.connetics.com

    Google Scholar 

  2. Connetics Corporation. Connetics Announces Positive Results from Velac Phase III Pivotal Trials. Media Release: 23 Mar 2004. Available from URL: http://www.connetics.com

    Google Scholar 

  3. Connetics Corporation. Connetics Affirms Velac Patent Position. Media Release: 22 Nov 2004. Available from URL: http://www.connetics.com

    Google Scholar 

  4. Connetics Corporation. Connetics’?New Drug Application for Velac(R) Has Been Accepted for Filing by the FDA. Media Release: 25 Oct 2004. Available from URL: http://www.connetics.com

    Google Scholar 

  5. Connetics Corporation. Connetics Presents 11 Scientific Posters at American Academy of Dermatology’s 62nd Annual Meeting. Media Release: 6 Feb 2004. Available from URL: http://www.connetics.com

    Google Scholar 

  6. van Hoogdalem EJ, Terpstra IJ, Spiegel-Melsen D. Absorption of clindamycin and tretinoin from topically applied anti-acne formulations in man. European Journal of Clinical Pharmacology 52 (Suppl.): 152, 1997

    Google Scholar 

  7. Richter JR, Bousema MT, De Boulle KLVM. Efficacy of a fixed clindamycin phosphate 1.2%, tretinoin 0.025% gel formulation (Velac) in the topical control of facial acne lesions. Journal of Dermatological Treatment 9: 81–90, Jun 1998

    Article  CAS  Google Scholar 

  8. Zouboulis ChC, Derumeaux L, Decroix J, et al. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac Rm) applied once daily and a clindamycin lotion formulation (Dalacin T Rm) applied twice daily in the topical treatment of acne vulgaris. British Journal of Dermatology 143: 498–505, Sep 2000

    Article  PubMed  CAS  Google Scholar 

  9. Yaroshinsky A, Leyden J. The safety and efficacy of clindamycin [1% as clindamycin phosphate and tretinoin (0.025%)] for the treatment of acne vulgaris: a combined analysis of results from six controlled safety and efficacy trials conducted in Europe. Journal of the American Academy of Dermatology 50 (Suppl.): 23 (plus poster) abstr. P89, No. 3, Mar 2004

    Article  Google Scholar 

  10. Leyden J, Yaroshinsky A, Krochmal L. Tolerability assessment of combination clindamycin/tretinoin hydrogel for the treatment of acne vulgaris in 2219 subjects. Journal of the American Academy of Dermatology 52 (Abstr. Suppl.): 25, No. 3, Mar 2005

    Google Scholar 

  11. Krochmal L, Yaroshinsky A. The novel combination clindamycin/tretinoin hydrogel: a randomized, double-blind, active- and vehicle-controlled study. Journal of the American Academy of Dermatology 52 (Abstr. Suppl.): 23 (+ poster), No. 3, Mar 2005

    Google Scholar 

  12. Yaroshinsky A, Krochmal L. Acne treatment outcomes with a once-daily combination of clindamycin and tretinoin in hydrogel compared with single agents. Journal of the American Academy of Dermatology 52 (Abstr. Suppl.): 26 (plus poster) abstr. P163, No. 3, Mar 2005

    Google Scholar 

  13. Leyden J, Yaroshinsky A, Krochmal L. Two randomized, controlled trials of a combination clindamycin/tretinoin hydrogel, compared with each agent alone for the tratment of acne vulgaris in 2219 subjects. Journal of the American Academy of Dermatology 52 (Abstr. Suppl.): 25 (plus poster), No. 3, Mar 2005

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clindamycin/Tretinoin. Drugs R D 6, 231–234 (2005). https://doi.org/10.2165/00126839-200506040-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200506040-00006

Keywords